Contrave vs GLP-1: Which Weight-Loss Medication Fits You? (2026)
Contrave vs GLP-1 comes down to four things: safety, how much weight loss you can expect, whether you want a pill or a shot, and a cost you can keep paying. In their main clinical trials, Contrave averaged about 5% weight loss, while FDA-approved GLP-1 options ranged from about 7% to 21%, depending on the drug. These were separate trials, not head-to-head studies. Contrave is four pills a day and costs no more than $99 a month through the maker’s program.
One popular claim about taking both together just got a major asterisk — the best-known supporting study was retracted in December 2025. And the old “Contrave is the pill, Wegovy is the shot” comparison is out of date in 2026: there are now FDA-approved GLP-1 pills too.
Published: · Last reviewed:
Affiliate disclosure: The RX Index may earn a commission from some telehealth links on this page, marked as sponsored. It never changes a drug’s label, price, or our verdict. Prescribing decisions are made by licensed clinicians, not by us.
Contrave vs GLP-1 at a glance
| Question | Contrave | GLP-1 medicines |
|---|---|---|
| What is it? | Naltrexone + bupropion. Not a GLP-1. | GLP-1 (or GLP-1/GIP) receptor agonists — a different drug class |
| How do you take it? | 4 pills a day | Daily pill, daily shot, or weekly shot — depends on the product |
| Weight loss (trials) | About 5% of body weight | About 7% to 21%, depending on the drug and dose |
| Cash price | No more than $99/month through the maker’s program | Roughly $299–$699/month for maintenance doses (starter doses can cost less) |
| Biggest deal-changer | Contrave’s hard stops (opioids, seizures, blood pressure) | Cost, coverage, and each product’s own safety rules |
Contrave is worth asking about if you:
- ✓Want a non-GLP-1 pill and would rather skip injections
- ✓Need a predictable low price — its program is no more than $99/month
- ✓Are okay taking four tablets a day
- ✓Don't have a health reason it's off-limits (more below)
An FDA-approved GLP-1 is worth asking about if you:
- ✓Want the biggest weight loss the trials show
- ✓Can get an FDA-approved brand covered, or can afford the cash price
- ✓Are fine with a daily pill, a daily shot, or a weekly shot — all exist now
Contrave is not a safe option if you:
- ■Have a seizure disorder or any history of seizures
- ■Take opioids regularly (long-term opioid use is a hard stop)
- ■Have uncontrolled high blood pressure, or anorexia or bulimia
These aren’t “maybe skip it” situations. They’re hard stops on the FDA label. We explain why below.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Not sure which of these even fits you?
The right GLP-1 provider isn’t the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred form (injection or oral), and your budget.
Compare treatment paths with Find My GLP-1 Path →Free · 60 seconds · no account needed
Contrave vs GLP-1: what’s the bottom line?
In their trials, today’s FDA-approved GLP-1 medicines produced more weight loss than Contrave. Contrave’s active group averaged about 5% of body weight; the GLP-1 options ranged from about 7% for Saxenda up to about 21% for Zepbound. Contrave’s real strengths are different: it’s a non-GLP-1 pill, and it has a set cash price of no more than $99 a month.
The damaging admission: Contrave usually produces less weight loss than the GLP-1s, and it’s four pills a day instead of one. If your only goal is the biggest possible drop on the scale, and you can get an FDA-approved GLP-1 covered or afford it, Contrave probably isn’t your strongest first choice.
But that “flaw” doesn’t matter for a lot of people. Contrave isn’t trying to win the weight-loss race. Its two real advantages are: it’s a pill (no needles), and it has a set price of no more than $99/month. In its main trial (COR-I), 42% of people on Contrave lost at least 5% of their body weight — which may be exactly enough for a lot of people.
What changes the answer for you:
- •A hard stop — a health reason a drug is off-limits (Contrave and each GLP-1 have their own)
- •Whether you can afford the ongoing cost or get it covered
- •Whether you'd rather take a daily pill or a weekly shot
- •A specific condition — where one exact product has an extra approved use
Is Contrave a GLP-1?
No. Contrave is a combination of two older medicines — naltrexone and bupropion — that work on the brain’s appetite and reward signals. GLP-1 medicines are a completely different class that act like a gut hormone called GLP-1, which your body releases after eating, to slow digestion and keep you full longer.
What’s actually in Contrave?
Contrave (made by Currax Pharmaceuticals, FDA-approved in 2014) has two active ingredients:
- •Naltrexone — normally used to help with alcohol or opioid dependence
- •Bupropion — an antidepressant also used to help people quit smoking
Together they act on the parts of the brain that control hunger and cravings. Contrave’s own FDA label says the exact reason this combination causes weight loss isn’t fully understood.
How do GLP-1 medicines work?
“GLP-1” is a hormone your gut releases after you eat. These medicines act like that hormone — slowing how fast your stomach empties and turning down appetite.
- •Semaglutide (Wegovy) — GLP-1 receptor agonist
- •Tirzepatide (Zepbound) — works on two receptors (GLP-1 and GIP), which produced the largest average weight loss in this comparison
- •Orforglipron (Foundayo) — a once-daily oral GLP-1, FDA-approved April 1, 2026
Why “pill vs shot” is out of date in 2026
For years the shorthand was: Contrave is a pill, Wegovy is a shot. Not anymore. As of 2026, avoiding needles does not automatically mean choosing Contrave. The oral options now include:
| Medicine | Form | Note |
|---|---|---|
| Contrave | Oral pill | 4 tablets a day |
| Wegovy tablet | Oral GLP-1 pill | FDA-approved Dec 22, 2025; once-daily with strict timing |
| Foundayo | Oral GLP-1 pill | FDA-approved Apr 1, 2026; once-daily, no food rules |
If you want a pill, this comparison includes three oral choices: Contrave, the Wegovy tablet, and Foundayo. They’re not interchangeable — different classes, different results, different prices.
Which causes more weight loss — Contrave or a GLP-1?
In their main clinical trials, GLP-1 medicines produced larger average weight loss than Contrave. Contrave averaged about 5% of body weight; the GLP-1 options ranged from about 7% up to about 21%, depending on the exact drug and dose. Because these came from separate trials with different patients and rules, treat them as context — not a promise of what you’ll lose.
Read this before the table.
These are separate pivotal trials, not one head-to-head study. The patients, trial lengths, doses, and math were all different. These figures show each product’s evidence. They do not prove one drug would beat another for the same person.
| FDA-approved option | Form & dose | Trial length | Avg. weight change (drug vs. placebo) | Lost at least 5% (drug vs. placebo) |
|---|---|---|---|---|
| Contrave | Naltrexone/bupropion pills | 56 weeks | −5.4% vs. −1.3% | 42% vs. 17% |
| Saxenda (3 mg) | Daily liraglutide shot | 56 weeks | −7.4% vs. −3.0% | 62% vs. 34% |
| Foundayo (17.2 mg) | Daily orforglipron pill | 72 weeks | −11.1% vs. −2.1% | 72% vs. 27% |
| Wegovy tablet (25 mg) | Daily semaglutide pill | 64 weeks | −13.6% vs. −2.4% | 76% vs. 31% |
| Wegovy shot (2.4 mg) | Weekly semaglutide shot | 68 weeks | −14.9% vs. −2.4% | 84% vs. 31% |
| Wegovy shot (7.2 mg) | Weekly semaglutide shot | 72 weeks | −18.8% vs. −3.9% | 89% vs. 38% |
| Zepbound (15 mg) | Weekly tirzepatide shot | 72 weeks | −20.9% vs. −3.1% | 91% vs. 35% |
Sources: current FDA prescribing information and pivotal trials for each drug — Contrave (COR-I), Saxenda (SCALE), Foundayo (ATTAIN-1), Wegovy tablet and shots (OASIS and STEP), Zepbound (SURMOUNT-1). Figures checked July 21, 2026. These are results from separate adult trials, not from a single head-to-head study.
Two things this table quietly tells you:
- 1.The placebo column matters. Every group lost some weight, because everyone also changed their diet and activity. The gap between the drug and placebo shows what the medicine added. Any page showing you only the drug’s number is hiding half the picture.
- 2.Watch out for “Contrave gets you to 12%” claims. Some sites quote a higher Contrave number, but they’re using a responder-enriched group (people who had already hit an early weight-loss mark) and placing it next to everyone-included GLP-1 numbers. That’s apples to oranges.
Contrave vs Wegovy
Wegovy’s trial average was higher than Contrave’s — roughly 15% for the standard Wegovy shot versus about 5% for Contrave, in separate studies. Wegovy now comes as a pill and a shot, so this is no longer a “pill vs needle” comparison.
Contrave vs Zepbound
Zepbound 15 mg showed the largest average weight loss in this group — about 21%. It’s a weekly shot with its own price, its own safety rules, and that two-receptor design. If maximum weight loss is your top priority and you qualify, Zepbound is often the biggest hitter. Contrave isn’t competing on that number, and it doesn’t claim to.
Contrave vs an oral GLP-1 (the real 2026 matchup)
If you want a pill, the honest comparison isn’t Contrave vs a needle — it’s Contrave vs an oral GLP-1 (the Wegovy tablet or Foundayo). On average weight loss, the oral GLP-1s did more in their trials. On price and safety fit, Contrave can still win for the right person. The cost and safety sections below are where this gets decided.
Who can take Contrave or a GLP-1?
All of the adult medicines compared here are generally for adults with obesity (BMI 30 or higher), or adults who are overweight (BMI 27 or higher) plus at least one weight-related health condition like high blood pressure or high cholesterol — used alongside a reduced-calorie diet and more activity. The exact rules differ by product.
A quick reality check: these are prescription medicines, and a clinician decides if you qualify. Your BMI, your other health conditions, your other medicines, and your history all factor in. This comparison helps you know which options to ask about — not to decide your eligibility.
How do you actually take each one?
How a medicine fits your day is a real part of this decision, not a footnote. Contrave is four pills a day and takes about four weeks to reach the full dose. GLP-1s range from a once-daily pill with no food rules (Foundayo) to a once-daily pill with strict timing (the Wegovy tablet) to daily or weekly shots.
| Medicine | How often | The daily routine |
|---|---|---|
| Contrave | Pills, twice a day | Builds up over ~4 weeks to 2 tablets in the morning and 2 at night. Don’t take it with a high-fat meal (it can raise the risk of seizures). |
| Foundayo | Pill, once a day | Any time of day, with or without food or water — the most flexible of the pills |
| Wegovy tablet | Pill, once a day | On an empty stomach with a small sip of water, then wait 30 minutes before food, drink, or other pills |
| Saxenda | Shot, once a day | A daily injection you give yourself |
| Wegovy shot | Shot, once a week | One injection per week |
| Zepbound | Shot, once a week | One injection per week — “set it and forget it” schedule |
If a simple once-daily routine matters most, Foundayo is the most flexible of the pills. If “set it and forget it” is your thing, a weekly shot may actually be easier than remembering pills every day.
Which option fits your situation better?
The better fit depends on your hard stops, your other medicines, your budget or coverage, and whether you’d rather take a pill or a shot — not just the biggest trial number. A single safety hard stop can outweigh every average on the chart.
Ask about a GLP-1 if the biggest weight loss is your #1 goal
- ✓You understand these are separate-trial figures, not a personal guarantee
- ✓No safety reason rules out the specific GLP-1
- ✓You can cover the cost or get it through insurance
- ✓A daily pill or a weekly shot works for your life
Ask about Contrave if a low, set price and a non-GLP-1 pill matter most
- ✓The $99/month program genuinely makes it affordable for you
- ✓Four pills a day is realistic
- ✓No hard stop applies to you
- ✓You accept that its average weight loss was lower than the GLP-1s
If you want a pill, compare three options — not one
Don’t assume “pill” means Contrave. Weigh Contrave, the Wegovy tablet, and Foundayo on results, price, and daily routine. They are not the same medicine.
If you take opioids — or might need them
Because Contrave contains naltrexone (which blocks opioids), long-term opioid use is a hard stop. If you might need opioids now and then — for surgery or an injury — that’s not an automatic no, but tell your prescriber before you start.
⚠️ Serious safety point:
Never try to override the opioid block by taking more opioids. Contrave’s label warns this can cause life-threatening intoxication or a fatal overdose — and your sensitivity to opioids can be higher after you stop Contrave.
Seizure history, eating disorder, or uncontrolled blood pressure
These are hard stops on Contrave’s label — anorexia or bulimia, a seizure disorder or history, and uncontrolled high blood pressure. Not “probably fine.” If any apply to you, Contrave is off the table, and a GLP-1 or another path is where your conversation should start.
Free · compares FDA-approved options by form, budget, insurance, and your state before you pick a provider
How much do Contrave and GLP-1 medicines cost in 2026?
Contrave’s program price is no more than $99 a month. FDA-approved GLP-1 brands run higher — roughly $299 to $699 a month for maintenance doses, before any separate telehealth fee. Starter doses can cost less (around $149), and insurance can change the math completely. Compare the maintenance price and the yearly cost, not the first-month teaser.
| Option | How it’s taken | Cash price (maintenance) | The catch to know |
|---|---|---|---|
| Contrave | 4 pills/day | No more than $99/month | An optional online visit fee (~$45) applies if you use the maker’s telehealth to get prescribed |
| Foundayo | Daily pill | $299/month offer; $349 regular | Offer requires next refill within 45 days and can change |
| Wegovy tablet | Daily pill | $299/month | Strict daily timing (empty stomach, wait 30 min) |
| Wegovy shot (2.4 mg) | Weekly shot | $349/month | Lower new-patient prices are temporary |
| Wegovy shot (7.2 mg) | Weekly shot | $399/month | Higher dose; still a clinical decision |
| Zepbound (15 mg) | Weekly shot | $449/month offer; $699 regular | Offer requires refill within 45 days and can change |
Prices are manufacturers’ current self-pay program prices, checked July 21, 2026. Starter or titration doses can run around $149. Saxenda doesn’t have a comparable low self-pay maintenance price and carries a list price around $1,349/month before insurance or savings. Prices change; confirm at the source.
Contrave without insurance
The maker’s CONTRAVE Connex program (formerly CurAccess) lists Contrave at no more than $99/month with free shipping for eligible cash-paying patients. Without the program, retail Contrave can run $500–$800+ a month — which is exactly why that $99 number is what matters. Over a year, that’s roughly $1,200 through the program.
GLP-1 without insurance
At maintenance doses, expect roughly $3,600 to $8,400+ a year depending on the drug and dose. Note that injectable fills usually cover 28 days, so a full year is about 13 fills, not 12. Always ask: what will this cost me in month six, not month one?
How telehealth fees change the picture
Many people get these medicines through a telehealth provider, which often charges its own fee on top of the medication. Two FDA-approved-focused options:
Ro — Sponsored
Carries FDA-approved GLP-1 medicines including Zepbound and Foundayo, and runs a free insurance coverage checker. Membership: $39 first month, $149/month monthly, or as low as $74/month annual — medication billed separately.
Check GLP-1 coverage with Ro →Sesame — Sponsored
A marketplace where you choose your own provider; pricing varies by provider and plan, and medication is separate.
See Sesame providers → (sponsored affiliate link, opens in a new tab)
Two ways forward, no pressure:
Official manufacturer program — not an affiliate link
Sponsored · Ro membership and medication billed separately
Which has worse side effects — Contrave or a GLP-1?
There’s no honest single “worse.” The side-effect patterns are different. Contrave commonly causes nausea, constipation, headache, and trouble sleeping. GLP-1 medicines most often cause stomach problems like nausea, vomiting, and diarrhea. Each also carries a boxed warning — the FDA’s most serious kind — and which one is riskier depends on your health history.
Common Contrave side effects
From the FDA label (most common): nausea, constipation, headache, vomiting, dizziness, trouble sleeping (insomnia), dry mouth, and diarrhea.
Boxed warning (bupropion):
Contrave carries the FDA’s boxed warning about suicidal thoughts and behaviors — from studies of antidepressants, where increased risk was seen in children, teens, and young adults up to age 24. Contact a healthcare provider right away if you notice new or worsening mood changes or thoughts of self-harm. In crisis, call or text 988.
Common GLP-1 side effects
Mostly stomach-related: nausea, vomiting, diarrhea, and constipation. GLP-1 doses are increased slowly to reduce these. Don’t assume every GLP-1 is identical — check the specific product’s label.
Boxed warning (GLP-1s):
FDA-approved GLP-1 weight-loss medicines carry a boxed warning about thyroid C-cell tumors seen in animal studies. Not for people with a personal or family history of medullary thyroid cancer or MEN 2.
Which other medicines matter with Contrave?
Bring your full medication list to your clinician, but a few interactions matter especially: other medicines containing bupropion, MAOIs (older antidepressants), opioids, and medicines that lower the seizure threshold. Some medicines processed by the liver can interact too. This isn’t the full list — that’s a conversation with your prescriber or pharmacist.
We won’t hand you a fake “Contrave: 7/10” safety rating — that would be inventing precision that doesn’t exist. Frequency numbers come from different trials. Severity matters as much as how often something happens. And your other medicines change your personal risk.
Who should not take Contrave or a GLP-1?
Contrave is off-limits for people with several specific conditions. GLP-1 medicines have their own separate rules. You can’t take one drug’s safety rules and assume they cover the whole category.
Contrave hard stops (from the FDA label)
Do not take Contrave if you have any of these:
- ■Uncontrolled high blood pressure
- ■A seizure disorder, or any history of seizures
- ■Use of another medicine that contains bupropion
- ■Anorexia nervosa or bulimia
- ■Long-term use of opioids, or you're in opioid withdrawal
- ■Stopping alcohol, sedatives, or seizure medicines suddenly
- ■Use of an MAOI now or in the last 14 days
- ■A known allergy to any ingredient
GLP-1 hard stops and cautions
These are product-specific — check the exact drug’s label. The true hard stops for FDA-approved GLP-1 weight-loss medicines are:
- ■Personal or family history of medullary thyroid cancer
- ■MEN 2 (a rare inherited condition)
- ■A prior serious allergic reaction to that drug
Things like pancreatitis or gallbladder problems are cautions your doctor weighs — not automatic hard stops. Don’t lump the two together.
If you’re pregnant, planning a pregnancy, or on birth control pills
- •These medicines aren’t used for weight loss during pregnancy — stop if you become pregnant.
- •Wegovy should be stopped at least 2 months before a planned pregnancy.
- •Foundayo and Zepbound can make birth control pills work less well. You may need a backup method for a while after starting and after each dose increase.
One more Contrave-specific catch
Contrave can cause a false positive for amphetamines on a urine drug test. Tell the clinician or lab that you take it — a confirmatory test can tell the difference. Worth knowing before a work or medical screening.
Can you take Contrave and a GLP-1 together?
Don’t treat “Contrave plus a GLP-1” as a proven or do-it-yourself combination. The best-known study suggesting it added extra weight loss was retracted in December 2025 after reviewers found the analysis couldn’t be reproduced.
What happened, in order:
- 2024A study out of Vancouver reported that adding Contrave's ingredients on top of a GLP-1 led to more weight loss.
- 2024–25The finding spread across blogs, videos, and social media as "combine them for better results."
- Dec 2025The journal (International Journal of Obesity) had a statistics expert re-check the data.
- Dec 19, 2025The study was retracted — because its analysis was not fully reproducible. You can read the retraction notice at the International Journal of Obesity (nature.com/articles/s41366-025-02006-x).
What the retraction does mean:
That study can’t be used as proof the combination helps you lose more. Any page still citing it as evidence needs to update.
What it does not mean:
That every clinician-supervised use is automatically wrong, or that we have proof the combination is unsafe. It means the evidence for extra benefit isn’t there.
Questions to ask a clinician if a combination comes up:
- •Why this combination for me specifically?
- •What evidence supports it?
- •What side effects or interactions will we watch for?
- •What's the stopping rule?
- •How would my opioid needs be handled, given the naltrexone?
Can you switch from a GLP-1 to Contrave — or the other way?
Yes, a clinician might switch you because of cost, side effects, a weak response, a new hard stop, or your own preference. But there’s no one-size-fits-all internet schedule for switching.
| Reason for switching | What matters |
|---|---|
| Lost coverage | “My insurance won’t cover it” can mean very different things — benefit exclusion vs. PA denied vs. formulary change. The fix depends on which one it is. |
| It wasn’t working | Don’t judge a medicine before you’ve reached its full dose and given it the label’s check-in window. |
| Side effects | Don’t assume Contrave is “easier on the stomach” — nausea is one of its most common side effects too. The switch should target your specific problem. |
| Standard washout period | There is no single public rule. Your prescriber accounts for the exact medicine, dose, last dose date, reason for switching, and everything else you take. |
What to bring to the appointment:
- •The medicine name and your current dose
- •The date of your last dose
- •A quick timeline of side effects and weight changes
- •Your full medication list
- •Any coverage denial letter
- •Your blood-pressure history (matters for Contrave)
- •Whether you might need opioid pain treatment
What if Contrave or a GLP-1 isn’t working?
Don’t use one blanket rule for the whole category. Contrave’s label says to check your response after 12 weeks on the full dose and stop if you haven’t lost at least 5% of your weight. Saxenda’s label says to check at 16 weeks and stop if you’ve lost less than 4%. The other products have their own plans.
- •Contrave's rule is measured after 12 weeks at the full maintenance dose — not 12 weeks after your very first pill.
- •These are prescriber-managed decisions, not a cue to quit on your own.
- •Don't judge any of these medicines on a random deadline. Follow the product's own build-up and check-in plan — and call your prescriber sooner if side effects are severe.
What your clinician will usually reassess: whether you reached the full dose, side effects, your other medicines, any gaps in your fills, and whether the original goal still fits.
Do heart disease, MASH, or sleep apnea change the choice?
Yes — a specific product’s extra approved use can matter more than the general weight-loss comparison. Some GLP-1s have added FDA indications for specific conditions, while Contrave does not.
| Condition | Product with the extra indication | What it means |
|---|---|---|
| Established cardiovascular disease | Wegovy (pill and shot) | FDA-approved to lower the risk of major heart events in certain adults with heart disease plus overweight or obesity |
| MASH with moderate-to-advanced scarring | Wegovy shot only | FDA-approved use for a serious liver condition; Wegovy tablets and HD do not carry this indication |
| Moderate-to-severe obstructive sleep apnea | Zepbound | FDA-approved for sleep apnea in adults with obesity |
| All of the above | Contrave: N/A | Contrave’s effect on heart attacks, strokes, and related deaths has not been established |
If any of these conditions is part of your picture, mention it early — it may point clearly toward one product, and it’s exactly the kind of detail a clinician needs.
How we compared Contrave and GLP-1 treatment paths
✓ What we actually verified
We checked the current Contrave prescribing information; the current Wegovy, Zepbound, Foundayo, and Saxenda prescribing information and pivotal trials; the official Contrave, NovoCare, and Lilly self-pay price terms; and the December 2025 journal retraction of the best-known Contrave-plus-GLP-1 study. The prices shown are the manufacturers’ stated self-pay terms as of July 21, 2026, not independently transaction-tested.
We did not verify: your personal eligibility, your insurance coverage, your copay, your pharmacy’s stock, or how you’d respond to any medicine. Those are between you and a licensed clinician.
One more thing: as of our July 2026 review, we found no direct head-to-head trial that put Contrave against these GLP-1s in the same study. So every “which is stronger” answer here is a careful read across separate trials — not a settled contest.
A note on compounded GLP-1s
You’ll see ads for cheap “compounded” semaglutide and tirzepatide. We left them out of this comparison on purpose. Compounded versions are not FDA-approved — the FDA doesn’t review them for safety, effectiveness, and quality the way it reviews the brands. The FDA found the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, and the special allowance that let pharmacies mass-compound them has since ended. Compounded and FDA-approved are not the same thing. If that’s a path you’re weighing, the Find My GLP-1 Path tool can walk you through it honestly.
Frequently asked questions: Contrave vs GLP-1
Is Contrave a GLP-1?
No. Contrave is a combination of naltrexone and bupropion and belongs to a completely different drug class than GLP-1 medicines like semaglutide and tirzepatide.
Is Contrave the same as Ozempic?
No. Contrave is naltrexone/bupropion. Ozempic is a semaglutide product approved for type 2 diabetes and heart-risk reduction -- not for weight loss. The semaglutide approved for weight loss is Wegovy.
Which produces more weight loss, Contrave or a GLP-1?
In separate trials, the GLP-1 options produced more average weight loss than Contrave -- roughly 7% to 21% versus about 5%. But these weren't head-to-head studies, so they can't predict your personal result.
Is Contrave cheaper than a GLP-1?
Usually, yes. Contrave's program price is no more than $99/month, while FDA-approved GLP-1 maintenance doses run about $299 to $699/month. Insurance and provider fees can change your personal cost.
Are there GLP-1 pills for weight loss?
Yes. As of 2026, FDA-approved oral GLP-1 options include the Wegovy tablet (FDA-approved December 22, 2025) and Foundayo (orforglipron, FDA-approved April 1, 2026). Skipping shots doesn't automatically mean choosing Contrave.
Can you take Contrave with Wegovy or Zepbound?
Don't treat it as proven. The best-known study on combining them was retracted in December 2025 because its analysis couldn't be reproduced. Any off-label combination is a clinician's decision.
Can you take opioids while on Contrave?
Long-term opioid use is a hard stop for Contrave, because it contains naltrexone (which blocks opioids). Tell your prescriber about any current or expected opioid use before starting, and never try to override the block with more opioids -- the label warns this can be life-threatening.
Can you switch from Wegovy to Contrave?
A clinician may consider it, but there's no universal switching schedule. The exact drugs, doses, last dose date, reason for switching, and your other medicines all matter.
Which one works faster?
There's no honest universal answer -- the trials used different doses, timelines, and methods. And early weight change isn't the same as long-term success.
Will the weight come back if I stop?
Weight regain after stopping has been documented for semaglutide and tirzepatide specifically. How much comes back, and how fast, isn't the same for every medicine -- so don't trust any flat promise of 'no regain.'
Does insurance cover Contrave?
It depends on your plan. When it's not covered, the CONTRAVE Connex program offers a separate cash path of no more than $99/month for eligible patients.
What if I have heart disease, MASH, or sleep apnea?
Some specific products have extra approved uses -- Wegovy for heart-risk reduction and MASH, Zepbound for obstructive sleep apnea. Those are product-specific, not class-wide. Bring your exact diagnoses to your clinician.
Is compounded semaglutide part of this comparison?
No. This comparison covers FDA-approved medicines only. Compounded products are not FDA-approved and are a separate safety and legal decision.
Still not sure which path is right for you?
“Contrave vs GLP-1” doesn’t have one right answer — it has your right answer.
The honest truth is it comes down to a short list: your health history, your budget, your coverage, and whether you want a pill or a shot. Take the free 60-second matching quiz to get a personalized set of treatment paths with source-verified pricing.
Take the free GLP-1 matching quiz →Free · 60 seconds · no account needed
Sources
- 1.U.S. FDA — Contrave (naltrexone/bupropion) Prescribing Information, incl. Boxed Warning and Contraindications: accessdata.fda.gov/drugsatfda_docs/label/2025/200063s024s026lbl.pdf
- 2.CONTRAVE Connex / savings program terms: contrave.com/save
- 3.U.S. FDA — Foundayo (orforglipron) Prescribing Information: accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf; Eli Lilly ATTAIN-1 results and April 2026 approval: investor.lilly.com
- 4.Novo Nordisk — Wegovy (semaglutide) Prescribing Information (oral tablet and injection), OASIS/STEP trials; Wegovy pill FDA approval (Dec 22, 2025): novonordisk.com / novo-pi.com/wegovy.pdf
- 5.Eli Lilly — Zepbound (tirzepatide) Prescribing Information, SURMOUNT-1, and LillyDirect self-pay terms: lilly.com
- 6.Novo Nordisk — Saxenda (liraglutide) Prescribing Information, SCALE trials: novo-pi.com/saxenda.pdf
- 7.International Journal of Obesity — Retraction Note (Dec 19, 2025), GLP-1 + bupropion/naltrexone cohort study: nature.com/articles/s41366-025-02006-x
- 8.U.S. FDA — statements on unapproved/compounded GLP-1 drugs and post-shortage compounding policy: fda.gov
- 9.Ro and Sesame — current published provider pricing and coverage-checker pages: ro.co / sesamecare.com
By The RX Index Editorial Team — independent guidance for choosing your GLP-1 path.
How this page was produced: We reviewed current FDA prescribing information, the drugs’ pivotal trials, official manufacturer self-pay price pages, current telehealth provider pricing, and the December 2025 journal retraction record. We separated medical facts, current price facts, and our own judgment, and recorded the date we checked every time-sensitive claim.
This article is for general education. It is not medical advice, and it can’t account for your personal health history. Talk with a licensed clinician before starting, stopping, switching, or combining any medication. If you’re in crisis, call or text 988.
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 2 minutes · no signup